Andersson CR - Search Results

1

Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.

Andersson CR, Selvin T, Blom K, Rubin J, Berglund M, Jarvius M, Lenhammar L, Parrow V, Loskog A, Fryknäs M, Nygren P, Larsson R. Andersson CR, et al. Sci Rep. 2020 Aug 4;10(1):13124. doi: 10.1038/s41598-020-68986-0. Sci Rep. 2020. PMID: 32753665 Free PMC article.

2

In vitro drug sensitivity-gene expression correlations involve a tissue of origin dependency.

Andersson CR, Fryknäs M, Rickardson L, Larsson R, Isaksson A, Gustafsson MG. Andersson CR, et al. J Chem Inf Model. 2007 Jan-Feb;47(1):239-48. doi: 10.1021/ci060073n. J Chem Inf Model. 2007. PMID: 17238270

3

Improving Bayesian credibility intervals for classifier error rates using maximum entropy empirical priors.

Gustafsson MG, Wallman M, Wickenberg Bolin U, Göransson H, Fryknäs M, Andersson CR, Isaksson A. Gustafsson MG, et al. Among authors: andersson cr. Artif Intell Med. 2010 Jun;49(2):93-104. doi: 10.1016/j.artmed.2010.02.004. Epub 2010 Mar 27. Artif Intell Med. 2010. PMID: 20347582

4

Brunn: an open source laboratory information system for microplates with a graphical plate layout design process.

Alvarsson J, Andersson C, Spjuth O, Larsson R, Wikberg JE. Alvarsson J, et al. BMC Bioinformatics. 2011 May 20;12:179. doi: 10.1186/1471-2105-12-179. BMC Bioinformatics. 2011. PMID: 21599898 Free PMC article.

5

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance.

Fryknäs M, Gullbo J, Wang X, Rickardson L, Jarvius M, Wickström M, Hassan S, Andersson C, Gustafsson M, Westman G, Nygren P, Linder S, Larsson R. Fryknäs M, et al. BMC Cancer. 2013 Aug 6;13:374. doi: 10.1186/1471-2407-13-374. BMC Cancer. 2013. PMID: 23919498 Free PMC article.

6

A pragmatic definition of therapeutic synergy suitable for clinically relevant in vitro multicompound analyses.

Kashif M, Andersson C, Åberg M, Nygren P, Sjöblom T, Hammerling U, Larsson R, Gustafsson MG. Kashif M, et al. Mol Cancer Ther. 2014 Jul;13(7):1964-76. doi: 10.1158/1535-7163.MCT-13-0430. Epub 2014 Apr 22. Mol Cancer Ther. 2014. PMID: 24755197

7

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy.

Blom K, Nygren P, Alvarsson J, Larsson R, Andersson CR. Blom K, et al. Among authors: andersson cr. J Lab Autom. 2016 Feb;21(1):178-87. doi: 10.1177/2211068215598117. Epub 2015 Aug 5. J Lab Autom. 2016. PMID: 26246423

8

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index.

Kashif M, Andersson C, Hassan S, Karlsson H, Senkowski W, Fryknäs M, Nygren P, Larsson R, Gustafsson MG. Kashif M, et al. Sci Rep. 2015 Sep 22;5:14118. doi: 10.1038/srep14118. Sci Rep. 2015. PMID: 26392291 Free PMC article.

9

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.

Österroos A, Kashif M, Haglund C, Blom K, Höglund M, Andersson C, Gustafsson MG, Eriksson A, Larsson R. Österroos A, et al. Biochem Pharmacol. 2016 Oct 15;118:40-49. doi: 10.1016/j.bcp.2016.08.020. Epub 2016 Aug 24. Biochem Pharmacol. 2016. PMID: 27565890

10

Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.

Blom K, Nygren P, Larsson R, Andersson CR. Blom K, et al. Among authors: andersson cr. SLAS Technol. 2017 Jun;22(3):306-314. doi: 10.1177/2472630316686297. Epub 2017 Jan 31. SLAS Technol. 2017. PMID: 28378608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters